Leading Health IT Company has Implemented Cost Control Measures and Refocused Remaining Workforce Towards ChemoFx®
Acquisition Provides Operational Capital to Drive Health Lives Here Campaign and Expand Services into Cancer ManagementPITTSBURGH, PA / ACCESS Newswire / September 15, 2026 / (NASDAQ:MEDS) ("DataMEDS"), a Health IT company vertically integrating health data acquisition and transfer, today announced that it completed the acquisition of artificial intelligence cancer diagnostics laboratory business Helomics Corporation ("Helomics") from Axe Compute Inc. (NASDAQ:AGPU) ("Axe Compute" or the "Company
Axe Compute (AGPU) sold its AI cancer diagnostics laboratory business called Helomics to DataMEDS AI
Predictive Oncology Reports Third Quarter 2025 Financial Results and Provides Update on Digital Asset Strategy...
Investment creates the world’s first Strategic Compute Reserve Strategy complements Predictive Oncology’s AI/ML-driven drug discovery and development...
This is the newest page. Registered accounts read further back.